Characteristics | Number |
---|---|
Age: | |
Median | 54 years |
Range | 33-65 years |
Gender: | |
Male | 37 (90.2%) |
Female | 04 (09.8%) |
Primary site: | |
Oropharynx | 23 (56.1%) |
Larynx | 10 (24.4%) |
Hypopharynx | 08 (19.5%) |
Laterality (epicentre): | |
Right | 22 (53.7%) |
Left | 18 (43.9%) |
Midline | 01 (02.4%) |
American Joint Committee on Cancer (AJCC) staging: | |
Stage II | 09 (21.9%) |
Stage III | 17 (41.5%) |
Stage IV | 15 (36.6%) |
Radiotherapy technique: | |
Three-Dimensional Conformal Radiotherapy (3D-CRT) | 20 (48.8%) |
Intensity-Modulated Radiation Therapy (IMRT) | 21 (51.2%) |
Median (inter-quartile range) of mean parotid dose: | |
Ipsilateral parotid | 50.0 Gy (36.2-59.7) |
Contralateral parotid | 35.4 Gy (28.0-53.5) |
Concurrent chemotherapy: | |
Yes | 38 (92.6%) |
No | 03 (07.4%) |